PAULINE MAGARA: Open Payments
NPI 1164119467 · POTTSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 68 payments from 13 companies in 2025. Trend: 2023 $28 · 2024 $938 · 2025 $1,195
Food & beverage: $1,195
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $248 |
| Neurocrine BioSciences, Inc. | 6 | $230 |
| ABBVIE INC. | 22 | $166 |
| Janssen Pharmaceuticals, Inc | 4 | $116 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
| Alkermes, Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
Products named: REXULTI, INGREZZA, VRAYLAR, FANAPT, SPRAVATO, COBENFY, Auvelity, LYBALVI.
Industry payments across PA — which companies pay providers there.
